Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nvidia and Asias Three Chip Giants Capture Record Gains from AI Boom SpaceX and OpenAI Potential IPOs Could Surpass Berkshire Hathaway in Market Value Traders Suggest Microsoft Appoints New Trusted Technology Head to Balance AI Speed with Responsible Development IFB Industries Q4 Net Profit Doubles to Rs 4267 Crore Revenue Up 1233 Buffett Indicator Signals Potential Overvaluation Key Warning Signs Emerge for Equity Markets Ashland Inc ASH Q1 2026 Earnings Narrow EPS Miss Masks Underlying Resilience Shares Rally Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges LPL Financial Q1 2026 Earnings Earnings Slightly Ahead of Estimates Shares Edge Lower PeapackGladstone Financial Corporation Q1 2026 Earnings EPS Surges Past Estimates on Strong Core Performance UTHR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Medtronic MDT Dips 12 as Shares Approach Key Support Level Enerpac Tool Group EPAC Edges Higher Consolidation Near Resistance Signals Potential Breakout MettlerToledo MTD Holds Steady Near 1100 as Support Levels Are Tested Geron Corporation GERN Edges Higher Testing Key Resistance After Modest Gains Divis Laboratories Reports 13 Rise in Q4 Net Profit Revenue Up 10 Announces Rs 30 per Share Dividend TGI Fridays Expands Indian Footprint with New Delhi Restaurant Opening Aluminum Price Surge Strains US Companies Amid Iran Conflict Asian Philanthropy Could Face Pressure to Bridge Climate Aid Gap as Western Support Falters NexPoint Real Estate Finance NREF Slightly Declines Key Levels to Watch Darling Ingredients DAR Edges Higher Key Levels to Watch After a Modest Gain Pegasystems PEGA Edges Higher as Shares Hold Above Key Support LanzaTech Global LNZA Shares Slide 4 as Selling Pressure Intensifies Key Support Levels Tested Cohen Steers ClosedEnd Opportunity Fund FOF Nears Support After Minor Decline Phio Pharmaceuticals PHIO Holds Steady at 109 as Stock Consolidates Between Key Levels